The laboratory pattern of low T3 with normal or low-normal T4 and TSH in a critically ill patient is characteristic of euthyroid sick syndrome (also known as non-thyroidal illness syndrome). This is an adaptive response to severe illness, primarily caused by decreased peripheral conversion of T4 to T3. Treatment with thyroid hormone is not indicated and may be harmful. The most appropriate course of action is to manage the underlying critical illness and re-evaluate thyroid function after the patient has recovered.

This patient has subclinical hypothyroidism, defined by an elevated TSH with a normal free T4 level. While treatment for mild elevations (TSH < 10 µIU/mL) is controversial, there is general consensus to treat when the TSH is persistently > 10 µIU/mL, as this is associated with an increased risk of progression to overt hypothyroidism and potential cardiovascular effects. Since her TSH is persistently above 10, initiating levothyroxine therapy is the most appropriate step.

The combination of transient hyperthyroidism in the postpartum period with a non-tender goiter and a low radioactive iodine uptake is characteristic of postpartum thyroiditis. This condition is a form of destructive thyroiditis where preformed thyroid hormone is released from an inflamed gland. The low RAIU scan differentiates it from Graves' disease or a toxic adenoma, where uptake would be high. While factitious hyperthyroidism also causes low uptake, the presence of a goiter makes thyroiditis more likely.

This patient has refractory hypocalcemia in the setting of significant hypomagnesemia. Magnesium is a crucial cofactor for both the secretion of PTH from the parathyroid glands and for PTH action on target tissues. Severe hypomagnesemia can cause functional hypoparathyroidism and end-organ resistance to PTH, leading to hypocalcemia that is refractory to calcium replacement alone. The hypocalcemia will not correct until the magnesium deficit is repleted. Therefore, administering intravenous magnesium sulfate is the most critical next step.

The patient's phenotype (Albright hereditary osteodystrophy) combined with hypocalcemia and hyperphosphatemia is classic for pseudohypoparathyroidism type 1a. This is a genetic disorder characterized by end-organ resistance to parathyroid hormone (PTH). The kidneys and bones do not respond appropriately to PTH. In response to the persistent hypocalcemia, the parathyroid glands are appropriately stimulated and produce high amounts of PTH. Therefore, an elevated PTH level is expected, distinguishing this condition from true hypoparathyroidism where PTH would be low.

Both primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH) present with hypercalcemia and elevated or inappropriately normal PTH. The key differentiating feature is renal calcium handling. In PHPT, urinary calcium excretion is typically normal or high (>200 mg/24 hr). In FHH, a genetic disorder of the calcium-sensing receptor, the kidneys abnormally reabsorb calcium, leading to low urinary calcium excretion, typically <100 mg/24 hr. A calcium-to-creatinine clearance ratio <0.01 is also characteristic of FHH. The family history further supports FHH.

Amiodarone-induced thyrotoxicosis (AIT) has two main types. AIT Type 1 is an iodine-induced hyperthyroidism occurring in patients with pre-existing thyroid disease (e.g., latent Graves' or multinodular goiter). It is a state of true hormone overproduction, which is associated with increased blood flow (vascularity) on color Doppler ultrasound. AIT Type 2 is a destructive thyroiditis caused by a direct toxic effect of amiodarone, resulting in the release of preformed hormone and decreased vascularity. Therefore, increased vascularity points towards AIT Type 1.

This patient's presentation of a painful thyroid gland, preceding viral illness, elevated inflammatory markers (ESR), and transient hyperthyroidism is classic for subacute (de Quervain's) thyroiditis. The hyperthyroidism is due to the release of preformed hormone from the inflamed, damaged gland, not due to new hormone synthesis. Therefore, antithyroid drugs like methimazole are ineffective. The mainstay of treatment is supportive care, focusing on pain and inflammation control with NSAIDs for mild to moderate cases, or corticosteroids for severe cases. The condition is self-limited.

This patient's presentation of hyperthyroidism (suppressed TSH), atrial fibrillation, and a nodular goiter in an older adult is highly suggestive of toxic multinodular goiter (TMNG). In TMNG, multiple autonomous nodules develop that produce thyroid hormone independent of TSH stimulation. A thyroid scan will characteristically show multiple foci of increased radionuclide uptake corresponding to these hyperfunctioning nodules, with suppression of uptake in the normal surrounding thyroid tissue due to the low TSH level.